Health Care·Health Care Services·$2.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | +42.31% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.37 | N/A | +42.31% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management appears pleased with the EPS results, highlighting their commitment to improving operations. However, they did not provide specific guidance for future performance.
Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.
They emphasized ongoing efforts to improve operational efficiencies.
Management noted that they are focused on long-term growth strategies.
Guardian Pharmacy SV A's earnings report shows a strong EPS performance, beating expectations significantly. However, the stock reacted negatively, declining by 0.42%. The lack of revenue data and forward guidance may have contributed to investor caution following the announcement.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BETA TECHNOLOGIES IN A
Mar 9, 2026